NCT04787471 - Corneal Crosslinking for Treatment of Corneal Neovascularization | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

July 15, 2026

Study Completion Date

September 15, 2026

Conditions

Corneal Neovascularization

Interventions

COMBINATION_PRODUCT

30 minute photoactivation of riboflavin 0.1%

Use of riboflavin 0.1% eye drops and 3mW/cm2 UVA light for 30 minutes

COMBINATION_PRODUCT

10 minute photoactivation of riboflavin 0.1%

Use of riboflavin 0.1% eye drops and 9mW/cm2 UVA light for 10 minutes

Trial Locations (1)

RECRUITING

Price Vision Group, Indianapolis